In line with expectations, icariin therapy raised the mRNA and protein expression of PPARα as well as the mRNA levels of CPT1α, ACOX1, MCAD, and LCAD (Figure 4A,B). The gene discussed is CPT1A; the disease is long chain acyl-CoA dehydrogenase deficiency.